Setsuko K Chambers

  • 4252 Citations
  • 41 h-Index
1986 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Macrophage Colony-Stimulating Factor Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
fms Genes Medicine & Life Sciences
Endometrial Neoplasms Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Papillary Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1990 2009

Macrophage Colony-Stimulating Factor
Ovarian Neoplasms
RNA-Binding Proteins
Androgens
Exons
Macrophage Colony-Stimulating Factor
Urokinase-Type Plasminogen Activator
Ovarian Neoplasms
fms Genes
Urokinase Plasminogen Activator Receptors
fms Genes
Macrophage Colony-Stimulating Factor
RNA Stability
Dexamethasone
Breast Neoplasms
Macrophage Colony-Stimulating Factor
Platinum
Drug Resistance
Macrophage Activation
Macrophage Colony-Stimulating Factor Receptors

Research Output 1986 2019

  • 4252 Citations
  • 41 h-Index
  • 130 Article
  • 3 Chapter
  • 1 Conference contribution
3 Citations (Scopus)

BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

Lin, K. K., Harrell, M. I., Oza, A. M., Oaknin, A., Ray-Coquard, I., Tinker, A. V., Helman, E., Radke, M. R., Say, C., Vo, L. T., Mann, E., Isaacson, J. D., Maloney, L., O'Malley, D. M., Chambers, S. K., Kaufmann, S. H., Scott, C. L., Konecny, G. E., Coleman, R. L., Sun, J. X. & 5 othersGiordano, H., Brenton, J. D., Harding, T. C., McNeish, I. A. & Swisher, E. M., Feb 1 2019, In : Cancer discovery. 9, 2, p. 210-219 10 p.

Research output: Contribution to journalArticle

Platinum
Carcinoma
Mutation
DNA
Neoplasms

Circulating miRNA Profiling of Women at High Risk for Ovarian Cancer

Pandey, R., Woo, H. H., Varghese, F., Zhou, M. & Chambers, S. K., May 1 2019, In : Translational Oncology. 12, 5, p. 714-725 12 p.

Research output: Contribution to journalArticle

Open Access
MicroRNAs
Ovarian Neoplasms
Androgens
Down-Regulation
Serum

Comparison of Reproductive Function in Female TgMISIIR-TAg Transgenic and Wildtype C57BL/6 Mice

Hoyer, P. B., Rice, P. F., Howard, C. C., Koevary, J. W., Dominguez Cooks, J. P., Hutchens, G. V., Chambers, S. K., Craig, Z. R., Connolly, D. C. & Barton, J. K., Feb 1 2019, In : Comparative medicine. 69, 1, p. 16-21 6 p.

Research output: Contribution to journalArticle

Inbred C57BL Mouse
genetically modified organisms
mice
Oncogenic viruses
Animals
Macrophage Colony-Stimulating Factor
RNA Stability
Ovarian Neoplasms
Cells
Breast Neoplasms

Phenotype of vigilin expressing breast cancer cells binding to the 69 nt 3′UTR element in CSF-1R mRNA

Woo, H. H., Lee, S. C., Stoffer, J. B., Rush, D. & Chambers, S. K., Jan 1 2019, In : Translational Oncology. 12, 1, p. 106-115 10 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Phenotype
Messenger RNA
fms Genes
Breast